BioCentury
ARTICLE | Financial News

NeoStem raises $16.5M

July 20, 2011 12:21 AM UTC

Cell therapy company NeoStem Inc. (NYSE-A:NBS) raised $16.5 million through the sale of 13.8 million units at $1.20 in a follow-on underwritten by Lazard; JMP; Morgan Joseph; TriArtisan; Maxim Group; and National Securities. Each unit comprises a share and a five-year warrant to purchase 0.75 shares, with each whole warrant exercisable at $1.45. ...